Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site

Novo Nordisk’s new Denmark site will produce drugs for rare diseases, such as hemophilias. Separately, the pharma giant said all regulatory conditions have been met for Novo Holdings’ acquisition of Catalent, which will bring to Novo Nordisk three manufacturing sites for GLP-1 medications. The post Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New…

Facilities Built for the Future: 3 Healthcare Design Trends Emerging in 2025 and Beyond

Whether pursuing high-tech solutions, tapping into natural elements, or doubling down on smaller building sizes, the future of healthcare facilities design boils down to improving patient access and nurturing employee retention. The post Facilities Built for the Future: 3 Healthcare Design Trends Emerging in 2025 and Beyond appeared first on MedCity News.